Understanding anticoagulation therapy for stroke prevention and atrial fibrillation

Natalie Schellack, Heleen Esterhuizen, Gustav Schellack

Research output: Contribution to journalLiterature reviewpeer-review

3 Citations (Scopus)


Atrial fibrillation (AF) is a common cardiac rhythm disorder. Patients suffering from this condition are at an increased risk of stroke and other thromboembolic events. Available treatment options for the prevention of strokes in patients suffering from AF include warfarin, aspirin and the novel oral anticoagulants. Warfarin and aspirin reduce the risk of strokes in patients with AF and have been studied extensively. The novel oral anticoagulants are slowly beginning to make their way onto the South African market and are specifically highlighted in this article.
Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalSA Pharmaceutical Journal
Publication statusPublished - 8 Jul 2013
Externally publishedYes


Dive into the research topics of 'Understanding anticoagulation therapy for stroke prevention and atrial fibrillation'. Together they form a unique fingerprint.

Cite this